MarketPeel
Insider Trading Intelligence
KH

Kerr Holbrook

AVNS
SVP, CHIEF COMMERCIAL OFFICER · AVANOS MEDICAL, INC. · CIK 0001861246
FILING MIX · LIFETIME29%/71%
BUYS
7
SELLS
17
TOTAL VALUE
$1.38M
COMPANIES
1
ACTIVE SINCE
Mar 2022
HOLDINGS NOW
84,926
AVG SELL PX
$15.62
TRADE KIND
SHOWING 24 / 24
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 9 pending
Forward-return performance of every backtestable P/S trade by Kerr Holbrook, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+20.00%+4.20%+1.07%+3.13%+4.23%
14d5+20.00%+0.18%+2.35%-2.17%-2.27%
30d5+20.00%+2.46%-0.32%+2.78%+3.57%
60d5+20.00%+3.84%+3.56%+0.27%+5.00%
90d5+20.00%+22.50%+3.63%+18.86%+29.20%
180d5+20.00%+91.58%+12.39%+79.19%+107.38%
1y5(4 pending)+100.00%-12.74%+17.76%-30.49%-30.49%
2y5(5 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AVNS · 84,926 shares · as of Nov 18, 2025
024,71549,43074,14598,860202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 7 buys / 17 sellsCOVERAGE · 16 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, Chief Commercial Officer
13,834$11.00$152.2K85,026Nov 18, 2025Nov 19, 2025View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, Chief Commercial Officer
305$11.02$3.4K83,860Nov 18, 2025Nov 19, 2025View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, Chief Commercial Officer
761$11.01$8.4K84,165Nov 18, 2025Nov 19, 2025View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, Chief Commercial Officer
100$11.01$1.1K84,926Nov 18, 2025Nov 19, 2025View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
49,08849,088Mar 7, 2025Mar 11, 2025View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
22,87798,860Mar 7, 2025Mar 11, 2025View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, Chief Commercial Officer
3,590$15.30$54.9K75,983Mar 6, 2025Mar 10, 2025View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, Chief Commercial Officer
7,000$15.25$106.8K82,047Mar 6, 2025Mar 10, 2025View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, Chief Commercial Officer
2,474$15.30$37.9K79,573Mar 6, 2025Mar 10, 2025View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, Chief Commercial Officer
1,543$15.13$23.3K89,047Mar 4, 2025Mar 6, 2025View →
AVNS
AVANOS MEDICAL, INC.
PURCHASE
SVP, Chief Commercial Officer
5,14592,393Mar 4, 2025Mar 6, 2025View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, Chief Commercial Officer
1,803$15.13$27.3K90,590Mar 4, 2025Mar 6, 2025View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, Chief Commercial Officer
756$19.09$14.4K88,971Mar 18, 2024Mar 19, 2024View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, Chief Commercial Officer
2,840$19.09$54.2K86,131Mar 18, 2024Mar 19, 2024View →
AVNS
AVANOS MEDICAL, INC.
PURCHASE
SVP, Chief Commercial Officer
2,53189,727Mar 18, 2024Mar 19, 2024View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
36,573$19.14$700.0K89,814Mar 6, 2024Mar 7, 2024View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, Chief Commercial Officer
2,618$19.00$49.7K87,196Mar 6, 2024Mar 7, 2024View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, Chief Commercial Officer
1,502$18.76$28.2K52,310Mar 5, 2024Mar 6, 2024View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, Chief Commercial Officer
1,772$23.97$42.5K53,812May 8, 2023May 9, 2023View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, GM Chronic Care
1,513$29.62$44.8K55,584Mar 6, 2023Mar 7, 2023View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
24,23357,097Mar 6, 2023Mar 7, 2023View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, GM Chronic Care
615$22.75$14.0K32,105Nov 7, 2022Nov 8, 2022View →
AVNS
AVANOS MEDICAL, INC.
SALE
SVP, GM Chronic Care
743$27.74$20.6K32,720May 9, 2022May 11, 2022View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
12,94933,463Mar 4, 2022Mar 8, 2022View →
Other insiders · AVNS
Loading peer insiders…
About this filer
CIK 0001861246
ROLE
SVP, Chief Commercial Officer
PRIMARY
AVNS
COMPANIES
1
ACTIVE SINCE
Mar 2022
MARKETPEEL · /INSIDER/0001861246DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback